Fluidigm Corporation

4.70+0.0700+1.51%Vol 780.79K1Y Perf 153.51%
Apr 15th, 2021 16:00 DELAYED
BID4.69 ASK4.70
Open4.69 Previous Close4.63
Pre-Market- After-Market-
 - -%  - -
Target Price
12.00 
Analyst Rating
Moderate Buy 2.00
Potential %
155.32 
Finscreener Ranking
★★★     50.53
Insiders Trans % 3/6/12 mo.
-/-100/-100 
Value Ranking
★★+     48.51
Insiders Value % 3/6/12 mo.
-/-100/-100 
Growth Ranking
★★★     53.80
Insiders Shares Cnt. % 3/6/12 mo.
-/-100/-100 
Income Ranking
 —    -
Market Cap350.37M 
Earnings Rating
Strong Sell
Price Range Ratio 52W %
28.17 
Earnings Date
6th May 2021

Today's Price Range

4.634.81

52W Range

1.6612.45

5 Year PE Ratio Range

-2.50-3.30

Summary:

Neutral

Technical Indicators: Buy
Moving Averages: Sell
Performance
1 Week
2.17%
1 Month
3.07%
3 Months
-23.95%
6 Months
-30.37%
1 Year
153.51%
3 Years
-23.82%
5 Years
-48.35%
10 Years
-69.12%

TickerPriceChg.Chg.%
FLDM4.700.07001.51
AAPL134.502.47001.87
GOOG2 296.6641.82001.85
MSFT259.503.91001.53
XOM56.98-0.3400-0.59
WFC42.240.25000.60
JNJ160.390.47000.29
FB307.825.00001.65
GE13.55-0.1300-0.95
JPM152.170.96000.63
Financial StrengthValueIndustryS&P 500US Markets
1.70
2.20
0.40
0.69
-14.10
Leverage Ratio 2.20
ProfitabilityValueIndustryS&P 500US Markets
58.30
-36.60
-23.60
-57.80
-32.84
RevenueValueIndustryS&P 500US Markets
110.53M
1.48
10.05
3.73
Earnings HistoryEstimateReportedSurprise %
Q04 2020-0.09-0.18-100.00
Q03 2020-0.10-0.0370.00
Q02 2020-0.15-0.1220.00
Q01 2020-0.14-0.16-14.29
Q04 2019-0.13-0.0746.15
Q03 2019-0.14-0.140.00
Q02 2019-0.12-0.15-25.00
Q01 2019-0.14-0.18-28.57
Earnings Per EndEstimateRevision %Trend
3/2021 QR-0.06-20.00Negative
6/2021 QR-0.04-33.33Negative
12/2021 FY-0.1313.33Positive
12/2022 FY-0.05--
Next Report Date6th May 2021
Estimated EPS Next Report-0.06
Estimates Count1
EPS Growth Next 5 Years %25.00
Volume Overview
Volume780.79K
Shares Outstanding74.55M
Trades Count4.71K
Dollar Volume21.05M
Avg. Volume2.58M
Avg. Weekly Volume914.52K
Avg. Monthly Volume1.04M
Avg. Quarterly Volume2.76M

Fluidigm Corporation (NASDAQ: FLDM) stock closed at 4.7 per share at the end of the most recent trading day (a 1.51% change compared to the prior day closing price) with a volume of 781.29K shares and market capitalization of 350.37M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Diagnostics & Research industry, Healthcare sector and employs 566 people. Fluidigm Corporation CEO is Stephen Christopher Linthwaite.

The one-year performance of Fluidigm Corporation stock is 153.51%, while year-to-date (YTD) performance is -21.67%. FLDM stock has a five-year performance of -48.35%. Its 52-week range is between 1.66 and 12.45, which gives FLDM stock a 52-week price range ratio of 28.17%

Fluidigm Corporation currently has a PE ratio of -6.40, a price-to-book (PB) ratio of 2.53, a price-to-sale (PS) ratio of 3.11, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -17.30%, a ROC of -19.06% and a ROE of -34.62%. The company’s profit margin is -32.84%, its EBITDA margin is -23.60%, and its revenue ttm is $110.53 Million , which makes it $1.48 revenue per share.

Of the last four earnings reports from Fluidigm Corporation, there were 2 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $-0.06 for the next earnings report. Fluidigm Corporation’s next earnings report date is 06th May 2021.

The consensus rating of Wall Street analysts for Fluidigm Corporation is Moderate Buy (2), with a target price of $12, which is +155.32% compared to the current price. The earnings rating for Fluidigm Corporation stock is Strong Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Fluidigm Corporation has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Fluidigm Corporation has a Neutral technical analysis rating based on Technical Indicators (ADX : 17.02, ATR14 : 0.42, CCI20 : 76.36, Chaikin Money Flow : 0.14, MACD : -0.43, Money Flow Index : 60.32, ROC : 8.55, RSI : 36.82, STOCH (14,3) : 72.94, STOCH RSI : 1.00, UO : 51.89, Williams %R : -27.06), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Fluidigm Corporation in the last 12-months were: Bradley Allen Kreger (Option Excercise at a value of $0), Carlos V. Paya (Option Excercise at a value of $0), Colin McCracken (Option Excercise at a value of $0), Nicolas M. Barthelemy (Option Excercise at a value of $0), Stephen Christopher Linthwaite (Option Excercise at a value of $0), Stephen Christopher Linthwaite (Sold 84 820 shares of value $514 009 ), Vikram Jog (Option Excercise at a value of $0)

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (50.00 %)
2 (50.00 %)
3 (60.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
2 (50.00 %)
2 (50.00 %)
2 (40.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingModerate Buy
2.00
Moderate Buy
2.00
Moderate Buy
1.80

Fluidigm Corporation

Fluidigm Corp manufactures life science tools focused on the analysis of single cells and industrial applications of genomics. These tools are based on microfluidics and mass cytometry technologies. It sells instruments and consumables, including integrated fluidic circuits, assays, and reagents. Slightly more than half of the firm's revenue comes from the sale of Consumables. Fluidigm primarily sells its products to academic institutions, clinical laboratories, and biopharmaceutical companies. The majority of revenue is generated in the United States followed by EMEA and Asia-Pacific.

CEO: Stephen Christopher Linthwaite

Telephone: +1 650 266-6000

Address: 7000 Shoreline Court, South San Francisco 94080, CA, US

Number of employees: 566

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

50%50%

Bearish Bullish

42%58%

Bearish Bullish

67%33%

News

Stocktwits